» Articles » PMID: 3367302

Pyrimidine Dideoxyribonucleosides: Selectivity of Penetration into Cerebrospinal Fluid

Overview
Specialty Pharmacology
Date 1988 May 1
PMID 3367302
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Cerebrospinal fluid (CSF)/plasma ratios of 1 to 30% were obtained in rhesus monkeys for the 3'-azido- and 2',3'-dideoxy-analogs of thymidine, deoxycytidine and deoxyuridine. Penetration of thymidine and deoxyuridine analogs was much greater than for deoxycytidine analogs. Octanol/buffer partition coefficients varied more than 30-fold, but did not correlate with CSF entry. Plasma protein binding was insignificant for all compounds. The presence or absence of the azido group at position 3' did not appear to influence the extent of CSF penetration. Although we do not fully understand the mechanistic basis for the penetration of these nucleosides into the CSF, it is apparent that the structural specificity is related more closely to the nucleobase than the sugar. Based upon elimination rates from the CSF after direct intrathecal injection, the differences in net penetration are determined by influx rather than efflux processes.

Citing Articles

CSF penetration by antiretroviral drugs.

Eisfeld C, Reichelt D, Evers S, Husstedt I CNS Drugs. 2012; 27(1):31-55.

PMID: 23160938 DOI: 10.1007/s40263-012-0018-x.


Serum and cerebrospinal fluid pharmacokinetics of intravenous and oral lamivudine in human immunodeficiency virus-infected children.

Mueller B, Lewis L, Yuen G, Farley M, Keller A, Church J Antimicrob Agents Chemother. 1998; 42(12):3187-92.

PMID: 9835513 PMC: 106021. DOI: 10.1128/AAC.42.12.3187.


Pharmacokinetics and distribution over the blood-brain barrier of zalcitabine (2',3'-dideoxycytidine) and BEA005 (2', 3'-dideoxy-3'-hydroxymethylcytidine) in rats, studied by microdialysis.

Borg N, Stahle L Antimicrob Agents Chemother. 1998; 42(9):2174-7.

PMID: 9736530 PMC: 105766. DOI: 10.1128/AAC.42.9.2174.


Pharmacokinetics of the protease inhibitor KNI-272 in plasma and cerebrospinal fluid in nonhuman primates after intravenous dosing and in human immunodeficiency virus-infected children after intravenous and oral dosing.

Mueller B, Anderson B, Farley M, Murphy R, Zuckerman J, Jarosinski P Antimicrob Agents Chemother. 1998; 42(7):1815-8.

PMID: 9661027 PMC: 105689. DOI: 10.1128/AAC.42.7.1815.


1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity.

Daluge S, Good S, Faletto M, Miller W, St Clair M, BOONE L Antimicrob Agents Chemother. 1997; 41(5):1082-93.

PMID: 9145874 PMC: 163855. DOI: 10.1128/AAC.41.5.1082.